MedPath

InnovaGyn, Inc

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (100.0%)

Phase II Study of Ovulation in Obese Women

Phase 2
Recruiting
Conditions
Pregnancy Prevention
Interventions
First Posted Date
2024-03-12
Last Posted Date
2024-03-12
Lead Sponsor
InnovaGyn, Inc.
Target Recruit Count
22
Registration Number
NCT06306131
Locations
🇺🇸

Carolina Women's Research and Wellness Center, Raleigh, North Carolina, United States

Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days

Phase 2
Recruiting
Conditions
Pregnancy Prevention
Interventions
First Posted Date
2023-01-25
Last Posted Date
2024-03-12
Lead Sponsor
InnovaGyn, Inc.
Target Recruit Count
21
Registration Number
NCT05695352
Locations
🇺🇸

Carolina Women's Research and Wellness Center, Raleigh, North Carolina, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.